UDIBI

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS

SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library VER MÁS

Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. VER MÁS

Transferon en el 2020 VER MÁS

Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. VER MÁS

Fecha de publicación: 2 abril de 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based...

Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...